Heidelberg Pharma AG (HPHA.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 10:51AM CEST. Market open.
Currency in EUR
Valuation measures4
| Market cap (intra-day) | 140.28M |
| Enterprise value | 107.80M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 15.09 |
| Price/book (mrq) | 3.03 |
| Enterprise value/revenue | 11.91 |
| Enterprise value/EBITDA | -6.39 |
Trading information
Stock price history
| Beta (5Y monthly) | -0.31 |
| 52-week change 3 | -25.63% |
| S&P500 52-week change 3 | 25.77% |
| 52-week high 3 | 4.0100 |
| 52-week low 3 | 2.6100 |
| 50-day moving average 3 | 3.0182 |
| 200-day moving average 3 | 3.1681 |
Share statistics
| Avg vol (3-month) 3 | 271 |
| Avg vol (10-day) 3 | 420 |
| Shares outstanding 5 | 46.6M |
| Implied shares outstanding 6 | 47.88M |
| Float 8 | 5.88M |
| % held by insiders 1 | 83.06% |
| % held by institutions 1 | 1.93% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:4 |
| Last split date 3 | 18 Jul 2014 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Nov 2023 |
| Most-recent quarter (mrq) | 29 Feb 2024 |
Profitability
| Profit margin | -201.94% |
| Operating margin (ttm) | -418.31% |
Management effectiveness
| Return on assets (ttm) | -22.11% |
| Return on equity (ttm) | -34.72% |
Income statement
| Revenue (ttm) | 9.05M |
| Revenue per share (ttm) | 0.20 |
| Quarterly revenue growth (yoy) | -38.90% |
| Gross profit (ttm) | N/A |
| EBITDA | -25.5M |
| Net income avi to common (ttm) | -18.28M |
| Diluted EPS (ttm) | -0.4000 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 32.65M |
| Total cash per share (mrq) | 0.7 |
| Total debt (mrq) | 5.24M |
| Total debt/equity (mrq) | 11.61% |
| Current ratio (mrq) | 2.92 |
| Book value per share (mrq) | 0.97 |
Cash flow statement
| Operating cash flow (ttm) | -33.68M |
| Levered free cash flow (ttm) | -22.09M |
© 2024 Yahoo. All rights reserved.